Login / Signup

Emergence of RAS mutations in patients with metastatic colorectal cancer receiving cetuximab-based treatment: a study protocol.

Shang-Hung ChenHsiang-Lin TsaiJeng-Kai JiangYung-Chuan SungChing-Wen HuangYu-Min YehLi-Tzong ChenJaw-Yuan Wang
Published in: BMC cancer (2019)
The date of trial registration ( NCT03401957 ) in this study was January 17, 2018.
Keyphrases
  • metastatic colorectal cancer
  • study protocol
  • randomized controlled trial
  • clinical trial
  • wild type
  • open label
  • phase ii
  • combination therapy
  • replacement therapy